Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally

<p>Background</p><p>There is widespread recognition that the existing global systems for innovation and access to medicines need reform. Billions of people do not have access to the medicines they need, and market failures prevent new drugs from being developed for diseases that pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Steven J. Hoffman, Karen So
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2015
Materias:
Acceso en línea:https://doaj.org/article/b0f2d6b36cd045649807476acaa1f77c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b0f2d6b36cd045649807476acaa1f77c
record_format dspace
spelling oai:doaj.org-article:b0f2d6b36cd045649807476acaa1f77c2021-12-02T02:41:47ZAssessing 15 Proposals for Promoting Innovation and Access to Medicines Globally2214-999610.1016/j.aogh.2015.02.004https://doaj.org/article/b0f2d6b36cd045649807476acaa1f77c2015-05-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2082https://doaj.org/toc/2214-9996<p>Background</p><p>There is widespread recognition that the existing global systems for innovation and access to medicines need reform. Billions of people do not have access to the medicines they need, and market failures prevent new drugs from being developed for diseases that primarily affect the global poor. The World Health Organization's Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) analyzed numerous proposals for reform. The aim of this article is to build on these previous inquiries.</p><p>Methods</p><p>We conducted a structured analysis that grouped proposals into five broad opportunities for global policy reform to help researchers and decision makers to meaningfully evaluate each proposal in comparison with similar proposals. Proposals were also analyzed along three important dimensions—potential health impact, financial implications, and political feasibility—further facilitating the comparison and application of this information.</p><p>Findings</p><p>Upon analysis, no one solution was deemed a panacea, as many (often competing) considerations need to be taken into account. However, some proposals, particularly product development partnership and prizes, appeared more promising and feasible at this time and deserve further attention.</p><p>Conclusion</p><p>More research is needed into the effectiveness of these mechanisms and their transferability across jurisdictions.Steven J. HoffmanKaren SoUbiquity PressarticleGlobal healthinnovationintellectual propertyinternational developmentmedicinespatentspharmaceuticalsInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 80, Iss 6, Pp 432-443 (2015)
institution DOAJ
collection DOAJ
language EN
topic Global health
innovation
intellectual property
international development
medicines
patents
pharmaceuticals
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle Global health
innovation
intellectual property
international development
medicines
patents
pharmaceuticals
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Steven J. Hoffman
Karen So
Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
description <p>Background</p><p>There is widespread recognition that the existing global systems for innovation and access to medicines need reform. Billions of people do not have access to the medicines they need, and market failures prevent new drugs from being developed for diseases that primarily affect the global poor. The World Health Organization's Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) analyzed numerous proposals for reform. The aim of this article is to build on these previous inquiries.</p><p>Methods</p><p>We conducted a structured analysis that grouped proposals into five broad opportunities for global policy reform to help researchers and decision makers to meaningfully evaluate each proposal in comparison with similar proposals. Proposals were also analyzed along three important dimensions—potential health impact, financial implications, and political feasibility—further facilitating the comparison and application of this information.</p><p>Findings</p><p>Upon analysis, no one solution was deemed a panacea, as many (often competing) considerations need to be taken into account. However, some proposals, particularly product development partnership and prizes, appeared more promising and feasible at this time and deserve further attention.</p><p>Conclusion</p><p>More research is needed into the effectiveness of these mechanisms and their transferability across jurisdictions.
format article
author Steven J. Hoffman
Karen So
author_facet Steven J. Hoffman
Karen So
author_sort Steven J. Hoffman
title Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
title_short Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
title_full Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
title_fullStr Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
title_full_unstemmed Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally
title_sort assessing 15 proposals for promoting innovation and access to medicines globally
publisher Ubiquity Press
publishDate 2015
url https://doaj.org/article/b0f2d6b36cd045649807476acaa1f77c
work_keys_str_mv AT stevenjhoffman assessing15proposalsforpromotinginnovationandaccesstomedicinesglobally
AT karenso assessing15proposalsforpromotinginnovationandaccesstomedicinesglobally
_version_ 1718402245398102016